Elo Mutual Pension Insurance Co Has $11.50 Million Stock Position in Elevance Health, Inc. $ELV

Elo Mutual Pension Insurance Co grew its holdings in shares of Elevance Health, Inc. (NYSE:ELV) by 21.9% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 35,583 shares of the company’s stock after buying an additional 6,387 shares during the period. Elo Mutual Pension Insurance Co’s holdings in Elevance Health were worth $11,498,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of ELV. Fisher Asset Management LLC bought a new position in Elevance Health during the third quarter worth $444,000. Fairtree Asset Management Pty Ltd raised its holdings in shares of Elevance Health by 29.1% during the third quarter. Fairtree Asset Management Pty Ltd now owns 3,242 shares of the company’s stock valued at $1,048,000 after purchasing an additional 730 shares during the period. Journey Strategic Wealth LLC boosted its position in shares of Elevance Health by 19.7% during the 3rd quarter. Journey Strategic Wealth LLC now owns 2,739 shares of the company’s stock worth $885,000 after purchasing an additional 450 shares in the last quarter. Trivium Point Advisory LLC boosted its holdings in Elevance Health by 32.8% in the third quarter. Trivium Point Advisory LLC now owns 835 shares of the company’s stock worth $270,000 after acquiring an additional 206 shares in the last quarter. Finally, American Century Companies Inc. grew its position in Elevance Health by 7.2% in the 3rd quarter. American Century Companies Inc. now owns 104,946 shares of the company’s stock valued at $33,911,000 after purchasing an additional 7,016 shares during the period. Institutional investors own 89.24% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the stock. Royal Bank Of Canada downgraded shares of Elevance Health from an “outperform” rating to a “sector perform” rating and set a $358.00 price objective on the stock. in a report on Tuesday, February 3rd. Wolfe Research set a $425.00 price target on shares of Elevance Health and gave the company an “outperform” rating in a research report on Thursday, January 8th. Wall Street Zen lowered Elevance Health from a “buy” rating to a “hold” rating in a research report on Sunday, February 8th. Guggenheim dropped their price target on shares of Elevance Health from $414.00 to $396.00 and set a “buy” rating on the stock in a research report on Thursday, January 29th. Finally, Weiss Ratings downgraded shares of Elevance Health from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 2nd. Twelve analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $390.55.

Elevance Health Stock Performance

NYSE:ELV opened at $320.65 on Monday. The business’s fifty day moving average is $350.23 and its 200 day moving average is $335.99. The firm has a market cap of $70.77 billion, a price-to-earnings ratio of 12.76, a PEG ratio of 1.77 and a beta of 0.51. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.54 and a current ratio of 1.54. Elevance Health, Inc. has a 52-week low of $273.71 and a 52-week high of $458.75.

Elevance Health (NYSE:ELV) last issued its earnings results on Wednesday, January 28th. The company reported $3.33 EPS for the quarter, topping the consensus estimate of $3.10 by $0.23. Elevance Health had a return on equity of 15.59% and a net margin of 2.84%.The business had revenue of $49.31 billion during the quarter, compared to the consensus estimate of $49.52 billion. During the same quarter last year, the company earned $3.84 EPS. The firm’s revenue was up 9.6% compared to the same quarter last year. Elevance Health has set its FY 2026 guidance at 25.500- EPS. Research analysts predict that Elevance Health, Inc. will post 33.96 EPS for the current year.

Elevance Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 25th. Investors of record on Tuesday, March 10th will be issued a dividend of $1.72 per share. This is a boost from Elevance Health’s previous quarterly dividend of $1.71. The ex-dividend date of this dividend is Tuesday, March 10th. This represents a $6.88 dividend on an annualized basis and a yield of 2.1%. Elevance Health’s payout ratio is currently 27.23%.

Elevance Health Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.